Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Bausch Health Companies Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
BHC
New York
2834
https://www.bauschhealth.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Bausch Health Companies Inc
Earnings Preview: Alignment Healthcare (ALHC) Q1 Earnings Expected to Decline
- Apr 25th, 2024 2:01 pm
Analysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for
- Apr 24th, 2024 2:01 pm
Bausch Health in 'Stronger Position' for Bausch + Lomb Distribution, RBC Says
- Apr 23rd, 2024 4:04 pm
10 Best Healthcare Stocks to Buy Under $20
- Apr 20th, 2024 1:16 pm
Bausch Health to Announce First-Quarter 2024 Results on May 2
- Apr 11th, 2024 8:22 pm
Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029
- Apr 11th, 2024 5:03 pm
Bausch wins US appeal to block Alvogen generic of diarrhea drug
- Apr 11th, 2024 4:40 pm
Will Bausch (BHC) Beat Estimates Again in Its Next Earnings Report?
- Apr 11th, 2024 4:10 pm
Acne Vulgaris Treatment PrARAZLO(TM) (Tazarotene Lotion, 0.045%) Now Available to Patients Through British Columbia PharmaCare Public Drug Plan
- Apr 11th, 2024 12:00 pm
CANADA STOCKS-TSX ends flat as gold stocks drop, mood cautious ahead of rate decision
- Apr 8th, 2024 9:33 pm
Bausch (BHC) Starts Litigation Against Amneal for Xifaxan
- Apr 8th, 2024 5:27 pm
BLCO vs. AVTR: Which Stock Is the Better Value Option?
- Apr 8th, 2024 3:40 pm
Bausch Health Announces Patent Lawsuit Against Amneal Pharmaceuticals
- Apr 5th, 2024 10:15 pm
/C O R R E C T I O N from Source -- Canadian Investment Regulatory Organization (CIRO) - Halts/Resumptions/
- Apr 3rd, 2024 4:05 pm
Here's Why Bausch Health (BHC) is a Strong Momentum Stock
- Apr 3rd, 2024 1:50 pm
Bausch Health, Canada Inc. Announces First Public Drug Plan Listings for (Pr)UCERIS(R) (budesonide) Aerosol Foam to Help Address the Unmet Need for the Treatment of Mild to Moderate Distal Ulcerative Colitis in Adults
- Apr 3rd, 2024 12:00 pm
Based on a New Survey, More Than Half of Surveyed IBS/CIC Patients Feel Alone in Their Experience but Also Find That Social Media Helps Create a Community and Inspires Healthcare Provider Conversations
- Apr 2nd, 2024 12:00 pm
Breakeven Is Near for Bausch Health Companies Inc. (NYSE:BHC)
- Apr 1st, 2024 3:22 pm
The Enduring Losses Incurred by Carl Icahn’s 10 Activist Targets over the Long Term
- Mar 28th, 2024 6:19 pm
Bausch (BHC) Soars 6.4%: Is Further Upside Left in the Stock?
- Mar 28th, 2024 9:23 am
Scroll